Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted July 28, 2008
Seizure of Xiadafil VIP Tablets After Company Refuses Recall
On July 24, 2008, the FDA announced that U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient.